Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) Bundle
Heilongjiang Interchina Water Treatment Co., Ltd. (600187.SS) presents a mixed picture for investors: reported revenue slid to CNY 179.16 million in 2024, a 20.73% drop year‑over‑year amid multi‑year declines, yet the company swung to a net income of CNY 43.58 million in 2024 from a loss in 2022; balance sheet strength is underscored by a net cash position of CNY 313.01 million and robust liquidity (current ratio 5.12, quick ratio 2.98), while valuation and profitability metrics raise questions-market cap stands at CNY 4.02 billion with a trailing P/E of 218.67, P/S 21.59 and P/FCF 373.06 even as gross margin is 28.51% and TTM net profit margin is 24.32%; examine the revenue trends, operating margin pressures (-8.23%), conservative debt profile (debt/equity 1.80%, debt/EBITDA 2.30), and growth opportunities such as potential CNY 300 million government contracts and targeted 10% market share gains through acquisitions in the full analysis below.
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) - Revenue Analysis
- 2024 reported revenue: CNY 179.16 million (decline of 20.73% vs. 2023).
- 2023 reported revenue: CNY 226.02 million (reported decline of 21.92% in 2023).
- Reported multi-year drops include a 24.71% decrease in 2022 and a 21.92% decrease in 2023.
- A separate reported metric indicates a 9.99% decrease in 2024 compared to 2023 (as noted in some company disclosures/quarteral comparisons).
- Revenue per employee: CNY 592,654.
- Revenue per share (latest quarter): CNY 2.78.
- Primary drivers cited for decline: increased competition and reduced market demand in the water treatment sector.
| Year | Revenue (CNY million) | YoY Change (%) |
|---|---|---|
| 2024 | 179.16 | -20.73 |
| 2023 | 226.02 | -21.92 |
| 2022 | N/A | -24.71 |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
- Implications for investors:
- Persistent negative growth pressures margins and cash-flow visibility.
- Lower revenue per employee suggests either overcapacity or workforce inefficiency given current demand levels.
- Revenue-per-share of CNY 2.78 (latest quarter) provides a per-share view of top-line generation for valuation and peer comparisons.
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) - Profitability Metrics
- Net income (2024): CNY 43.58 million (vs. net loss of CNY 115.75 million in 2022).
- TTM Net profit margin: 24.32% - strong conversion of revenue to bottom-line profit.
- Gross margin: 28.51% - indicates relatively efficient production and service delivery.
- Operating margin: -8.23% - operating expenses exceed operating income, signaling cost-control challenges.
- Return on equity (ROE): 0.43% - modest returns to shareholders.
- Return on assets (ROA): -0.27% - assets are not currently generating positive returns.
| Metric | Value | Notes / Comparative Point |
|---|---|---|
| Net Income (2024) | CNY 43.58M | Turnaround from CNY -115.75M in 2022 |
| Net Profit Margin (TTM) | 24.32% | High margin relative to peers in water-treatment services |
| Gross Margin | 28.51% | Reflects efficient cost of goods sold / direct service costs |
| Operating Margin | -8.23% | Negative - operating costs, SG&A pressure or one-off items |
| Return on Equity (ROE) | 0.43% | Low return for equity investors |
| Return on Assets (ROA) | -0.27% | Assets underutilized or carrying impairment/underperformance |
- Implications for investors:
- Net income recovery is a positive signal, but negative operating margin and ROA warrant scrutiny of cost structure and asset efficiency.
- High net and gross margins indicate pricing power or favorable mix, yet sustainable profitability depends on converting operating-level losses to breakeven or better.
- ROE near zero suggests limited shareholder value creation despite recent profit-monitor capital allocation and future earnings consistency.
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) - Debt vs. Equity Structure
Heilongjiang Interchina Water Treatment's capital structure shows a conservative use of leverage combined with strong short-term liquidity and a positive net cash position, while profitability and interest-bearing earnings are currently weaker.- Debt-to-Equity Ratio: 1.80% - very low leverage, equity-funded operations dominate.
- Debt-to-EBITDA: 2.30 - overall debt is ~2.3x annual EBITDA, a moderate servicing horizon.
- Interest Coverage Ratio: -3.20 - operating earnings are insufficient to cover interest expenses (negative due to operating loss or low EBIT).
- Current Ratio: 5.12 - ample short-term assets to meet liabilities.
- Quick Ratio: 2.98 - strong liquidity even excluding inventory.
- Net Cash Position: CNY 313.01 million - positive cash buffer for projects and expansion.
| Metric | Value | Implication |
|---|---|---|
| Debt-to-Equity | 1.80% | Minimal leverage; low financial risk from debt load |
| Debt-to-EBITDA | 2.30 | Debt manageable relative to operating cash flow |
| Interest Coverage | -3.20 | Inability of EBIT to cover interest; potential stress on profitability |
| Current Ratio | 5.12 | Very strong short-term solvency |
| Quick Ratio | 2.98 | High immediate liquidity without inventory reliance |
| Net Cash | CNY 313.01 million | Available liquidity for capex, working capital, or M&A |
- Low leverage reduces default risk and supports capacity to raise debt if needed.
- Negative interest coverage signals operating profitability weaknesses - monitor EBIT trends and margin recovery.
- Strong liquidity ratios and net cash provide a buffer to withstand short-term shocks and fund strategic initiatives.
- Debt-to-EBITDA near 2.3 is acceptable but reliant on EBITDA stability; a turnaround in earnings would markedly improve credit metrics.
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) - Liquidity and Solvency
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) displays a robust liquidity profile and conservative solvency metrics that signal strong short-term cover and low leverage on the balance sheet. Key metrics and cash-flow figures underline its capacity to fund operations, capital spending and strategic initiatives from internal resources.
- Current ratio: 5.12 - strong short-term financial health and ample working capital cushion.
- Quick ratio: 2.98 - good liquidity without reliance on inventory liquidation.
- Net cash position: CNY 313.01 million - provides flexibility for ongoing projects and potential expansion.
- Total assets: CNY 3,422.46 million; Total liabilities: CNY 170.07 million - low debt relative to asset base.
- Operating cash flow: CNY 26.89 million - positive cash generation from core operations.
- Free cash flow: CNY 10.77 million - sufficient to cover capital expenditures and reinvestment needs.
| Metric | Value (CNY) | Comment |
|---|---|---|
| Current ratio | 5.12 | High short-term liquidity |
| Quick ratio | 2.98 | Strong immediate liquidity excluding inventory |
| Net cash position | 313,010,000 | Available cash net of debt |
| Total assets | 3,422,460,000 | Scale of the balance sheet |
| Total liabilities | 170,070,000 | Low absolute liabilities |
| Operating cash flow | 26,890,000 | Cash from core operations |
| Free cash flow | 10,770,000 | Cash available after capex |
These figures point to a company with strong liquidity buffers and limited financial leverage, supporting operational continuity and strategic flexibility. For context on the company's strategic priorities that may influence future capital allocation, see Mission Statement, Vision, & Core Values (2026) of Heilongjiang Interchina Water Treatment Co.,Ltd.
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) - Valuation Analysis
This section breaks down key valuation metrics for Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) to help investors gauge how the market currently prices the company versus its fundamentals.
- Market capital structure: market capitalization and enterprise value provide a top-line view of size and capital structure.
- Relative valuation multiples: P/E, P/S, P/B and P/FCF highlight how earnings, sales, book value and cash flow are being valued by the market.
- Per-share metrics: EPS gives a per-share profitability snapshot that underlies many multiples.
| Metric | Value | Interpretation |
|---|---|---|
| Market Capitalization | CNY 4.02 billion | Equity market value |
| Enterprise Value (EV) | CNY 3.72 billion | Firm value including debt and cash |
| Trailing P/E | 218.67 | Very high multiple on earnings - market pricing implies strong growth expectations or very low current earnings |
| Price-to-Sales (P/S) | 21.59 | Stock priced highly relative to revenue |
| Price-to-Book (P/B) | 1.26 | Trading at modest premium to book value |
| EPS (Trailing) | CNY 0.01 | Low per-share earnings underpinning elevated P/E |
| Price-to-Free Cash Flow (P/FCF) | 373.06 | Extremely high valuation relative to free cash generation |
Key takeaways for investors:
- High P/E (218.67) driven by low EPS (CNY 0.01) - suggests the market expects future earnings expansion or reflects temporarily depressed earnings.
- P/S of 21.59 indicates revenue is being valued at a significant premium; compare to peers to assess relative premium.
- P/FCF of 373.06 signals very thin current free cash flow versus equity price; sensitivity to cash conversion is a risk factor.
- P/B at 1.26 shows moderate premium to book - not extreme on a book-value basis but elevated when combined with other multiples.
For additional context on ownership, trading behavior and investor composition, see: Exploring Heilongjiang Interchina Water Treatment Co.,Ltd. Investor Profile: Who's Buying and Why?
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) Risk Factors
Heilongjiang Interchina Water Treatment Co.,Ltd. faces a set of material risks that can influence cash flow, margins, and valuation. Below are the primary risk vectors, quantified impact scenarios, and operational considerations investors should monitor.- Competitive pressure: intensifying competition from national EPC firms, municipal operators, and specialized technology entrants may compress pricing and reduce win rates for new contracts.
- Regulatory and policy risk: tighter environmental standards, permit delays, or changes to subsidy and procurement rules can raise compliance costs and defer revenues.
- Execution and project risk: reliance on large-scale infrastructure projects creates exposure to schedule slippage, cost overruns, and contract disputes.
- Commodity and energy volatility: swings in steel, chemical reagents, and energy prices directly affect COGS and operating margins on multi-year contracts.
- Expansion and integration risk: entering new provinces or overseas markets can trigger integration, cultural, and local-partnership challenges.
- Macro and fiscal sensitivity: reduced government capex or an economic slowdown may materially cut public-sector orders and project pipelines.
| Risk Driver | Typical Short-Term Impact | Illustrative Financial Effect | Monitoring Metrics |
|---|---|---|---|
| Increased competition | Lower tender win-rate; pricing concessions | Win-rate down 5-10 ppt → revenue decline 3-8% | Bid success rate, order backlog (RMB) |
| Regulatory tightening | Higher compliance capex; permit delays | Incremental costs +1-4% of revenues; EBITDA margin -0.5-2 ppt | Compliance capex, approval lead-times |
| Project delays / execution | Revenue recognition pushed; liquidated damages | Revenue shift: 6-18 months delay → working capital stress; potential revenue loss 2-6% | Project schedule adherence, contract penalty exposure |
| Raw material & energy cost swings | Rising input costs; margin compression | Input cost +10% → gross margin decline 1-3 ppt; EBITDA -2-6% | Commodity indices (steel, chemicals), fuel costs |
| Market expansion risks | Integration & local execution issues | One-off integration costs 0.5-2% of revenue in target period | New-market EBITDA, partner performance metrics |
| Government capex reduction | Lower order intake; longer sales cycles | Order intake reduction 10-30% in severe cycles → revenue growth stalls | Public infrastructure budgets, tender volumes |
- Scenario analysis - sensitivity to key shocks (illustrative):
- 10% sustained increase in chemical/steel prices → operating margin contraction of ~2-4 ppt.
- One major project delayed by 12 months (RMB 200-500m contract) → EBITDA swing of tens of millions RMB in the affected year and higher working capital needs.
- Regulatory compliance upgrade across fleet requiring CAPEX equal to 1-3% of annual revenues → short-term free-cash-flow pressure.
- Mitigation levers the company can use include contract indexing clauses, diversified supplier sourcing, performance bonds, stronger project controls, and selective bid discipline.
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) - Growth Opportunities
Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) has multiple near- and medium-term growth levers that investors should watch. Key drivers include M&A, government infrastructure contracting, product/service diversification into sustainable energy, R&D-led efficiency gains, and continued process optimization.
- Strategic acquisitions: targeted bolt‑on purchases of smaller regional water-treatment firms could increase market share by ~10% within 18-36 months, accelerating top-line growth and geographic reach.
- Government partnerships: active pursuit of municipal and provincial water infrastructure projects with an addressable pipeline of contracts up to CNY 300 million per awarded program.
- Integrated solutions & sustainability: expansion of integrated water and green energy solutions aligns with national environmental policy and urbanization trends, improving bid win-rates for large-scale projects.
- R&D and proprietary tech: a focused R&D organization and in‑house technologies enhance treatment efficiency and lower operating costs versus peers.
- Process optimization track record: prior initiatives reduced operational costs by ~20%, creating margin headroom to fund growth or absorb competitive pricing.
- Diversification into green energy: entry into sustainable energy projects provides new revenue streams and de‑risking from pure water‑service cyclicality.
| Metric | Current / Baseline | Estimated Impact | Timing |
|---|---|---|---|
| Market share (regional) | Baseline | +10% via acquisitions | 18-36 months |
| Potential government contract value | - | Up to CNY 300,000,000 per program | Award cycle: 6-24 months |
| Operational cost reduction (historical) | - | 20% reduction realized | Recent 2-3 years |
| Revenue uplift from integrated solutions | Baseline revenue stream | Projected +8-15% incremental over 3 years | 36 months |
| New revenue from green energy projects | Minimal current exposure | Potential to contribute 5-10% of revenues within 3-5 years | 3-5 years |
Priority execution items for capturing these opportunities include disciplined M&A screening (target size, EBITDA multiples), strengthened public‑sector bidding capacity, accelerated commercialization of proprietary technologies, and reinvestment of efficiency savings into growth initiatives. For context on strategic positioning and corporate priorities, see Mission Statement, Vision, & Core Values (2026) of Heilongjiang Interchina Water Treatment Co.,Ltd.

Heilongjiang Interchina Water Treatment Co.,Ltd. (600187.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.